Boston Scientific is a major medical device company with a significant neuromodulation franchise spanning deep brain stimulation, spinal cord stimulation, and sacral neuromodulation. The Vercise Genus DBS system features multi-source current steering for precise therapeutic field shaping and competes in the approximately $2B global DBS market alongside Medtronic and Abbott. Boston Scientific emphasizes its directional programming tools and surgical planning visualization software as clinical differentiators.